AFXA fundamentals
CARL ZEISS MEDITEC ADR 1 financial statements, including revenue, expenses, profit, and loss
The total revenue of AFXA for the last semiannual is 948.32 M EUR, and it's 17.36% lower compared to the previous semiannual. The net income of H1 24 is 83.97 M EUR.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
TTM